https://orcid.org/0000-0003-2201-115X
References
- Mancini R, Kaster LM, Vu B, et al. Implementation of a pharmacist managed interdisciplinary oral chemotherapy program in a community cancer center. J Hematol Oncol Pharm 2011;1(2):23–30.
- National Community Oncology Dispensing Association. NCODA announces the defining of the medically integrated dispensing pharmacy [press release]. Available online at: www.ncoda.org/medically-integrated-dispensing-pharmacy/. Last accessed September 30, 2020.
- Hanna KS. NCODA patient surveys support the need for medically integrated pharmacies. AJMC. 2019;25(6): SP193–194.
- Howard A, Kerr J, McLain M, Modlin J. Financial impact from in-office dispensing of oral chemotherapy. J Oncol Pharm Pract. 2019;25(7):1570–1575.
- Carmichael JM, O’Connell MB, Devine B, et al. Collaborative drug therapy management by pharmacists. American College of Clinical Pharmacy. Pharmacotherapy. 1997;17(5):1050–1061.
- American Pharmacists Association Foundation and American Pharmacists Association. Consortium recommendations for advancing pharmacists’ patient care services and collaborative practice agreements. J Am Pharm Assoc. 2013;53:e132–e141.
- Wright AL, Matta SF, Kerr JR. Expansion of pharmacist practice in oral oncolytic therapy with a collaborative practice agreement. J Oncol Pharm Pract. 2020;26(8):1886–1893.